MARKER THERAPEUTICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.23 USD | +0.71% |
|
-1.40% | -23.09% |
| Apr. 30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
| Mar. 27 | North American Morning Briefing : Stocks Edge -2- | DJ |
Chart calendar Marker Therapeutics, Inc.
cf7ec39a.Z55jeh_Jr3Qk3odeGjzoyitZkkmY5Q2JEroPpoih4X4.BcYqEE3wnjtGuMoHKViAmBwLoiPcsDrdcddV89vjqz0k_yEXba_MHHyK8A~f518146bf28f05a90a6f222b13c70640
Upcoming events on Marker Therapeutics, Inc.
Past events on Marker Therapeutics, Inc.
| 2024-04-01 | Hematologic Malignancies Global Summit |
| 2024-03-26 10:00 am | H.C. Wainwright Cell Therapy Virtual Conference |
| 2024-03-25 05:45 pm | Q4 2023 Earnings Release |
| 2024-01-09 | Non Dilutive Funding Summit |
| 2024-01-07 | Biotech Showcase |
| 2023-11-09 05:00 pm | Q3 2023 Earnings Release |
| 2023-09-13 08:30 am | H.C. Wainwright Global Investment Conference |
| 2023-08-14 04:30 pm | Q2 2023 Earnings Release |
| 2023-06-06 09:00 am | Annual General Meeting |
| 2023-03-22 08:10 am | Q4 2022 Earnings Release |
| 2022-11-10 04:05 pm | Q3 2022 Earnings Release |
| 2022-09-15 09:20 am | Cantor Fitzgerald Cell & Gene Therapy Conference |
| 2022-08-11 04:22 pm | Interim 2022 Earnings Release |
| 2022-05-24 09:00 am | Annual General Meeting |
| 2022-05-13 07:00 am | Q1 2022 Earnings Release |
| 2022-05-05 08:45 pm | International Society for Cell & Gene Therapy Meeting - Abstract Number : 506 |
| 2022-05-05 08:45 pm | International Society for Cell & Gene Therapy Meeting - Abstract Number : 936 |
| 2022-05-05 08:45 pm | International Society for Cell & Gene Therapy Meeting - Abstract Number : 515 |
| 2022-05-05 08:45 pm | International Society for Cell & Gene Therapy Meeting - Abstract Number : 937 |
| 2022-03-17 05:45 pm | FY 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,21 0,00 - | 0,47 0,48 -3.46% | 1,24 0,00 - | 9,01 9,00 0.15% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -22,5 -23,2 2.92% | -28,9 -27,8 -3.86% | -39,5 -40,5 2.49% | 0,00 0,00 - | -18,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,4 -22,2 3.26% | -28,7 -27,7 -3.56% | -41,9 -42,3 0.95% | 0,00 0,00 - | -17,4 |
|
Net income Million USD | Released Forecast Spread | -21,4 -22,2 3.26% | -28,7 -27,7 -3.56% | -41,9 -42,3 0.95% | 0,00 0,00 - | -17,4 |
|
EPS USD | Released Forecast Spread | -4,70 -4,86 3.29% | -6,10 -5,90 -3.39% | -5,50 -5,73 3.93% | -3,58 -3,60 0.56% | -1,28 |
| Announcement Date | 12/03/20 | 09/03/21 | 17/03/22 | 22/03/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,24 0,00 - | 0,96 0,00 - | 0,79 2,50 -68.38% | 3,95 0,27 1381.07% | 3,31 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -9,76 -10,8 9.21% | -9,79 -11,2 12.55% | -9,28 -8,72 -6.46% | -7,02 -11,3 37.7% | -2,45 | -2,57 | -5,29 | -7,93 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,76 -10,8 9.38% | -9,91 -11,2 11.25% | -9,24 -8,74 -5.81% | -6,92 -10,9 36.23% | -2,26 | -2,42 | -5,17 | -7,53 | |
|
Net income Million USD | Released Forecast Spread | -9,76 -10,8 9.38% | -9,91 -11,2 11.25% | -9,24 -8,74 -5.81% | -6,92 -10,9 36.23% | -2,26 | -2,42 | -5,17 | -7,53 | |
|
EPS USD | Released Forecast Spread | -1,10 -1,28 13.73% | -1,20 -1,33 10% | -1,10 -1,05 -4.76% | -0,80 -1,30 38.46% | -3,27 -1,00 -227% | -0,25 | -0,27 | -0,37 | -0,39 |
| Announcement Date | 17/03/22 | 13/05/22 | 11/08/22 | 10/11/22 | 22/03/23 | - | - | - | - |
| 2024-05-06 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-06 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | PHARVARIS N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | NOVAVAX, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-07 01:00 am | VALNEVA: Q1 2024 Earnings Release |
| 2024-05-07 07:00 am | IONIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Past sector events for Marker Therapeutics, Inc.
| 2024-05-02 04:10 pm | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:05 pm | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:05 pm | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:01 pm | GALAPAGOS NV: Q1 2024 Earnings Release |
| 2024-05-02 08:00 am | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:05 am | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-02 06:30 am | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MRKR Stock
- Calendar Marker Therapeutics, Inc.
